Clinical Trials in Salt Lake City

Showing 4241-4260 of 12,670 trials

Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)

NCT04516213

This is a Multicenter, Open-label, Single-arm study evaluating the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG) in the Nutritional Management of Tube-fed Children Aged 1-4 Years over a 7 day period.

Enteral Nutrition

Société des Produits Nestlé (SPN)24 participantsStarted Feb 2020

Hollywood, Florida, United States • Chicago, Illinois, United States • Indianapolis, Indiana, United States +2 more locations

COMPLETEDPhase 1< 1 mile

A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993

NCT06508762

The purpose of the study is to evaluate the pharmacokinetics (PK), safety, and tolerability of VX-993 in healthy adult participants.

Pain

Vertex Pharmaceuticals Incorporated24 participantsStarted Jul 2024

Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

NCT03265288

An International Phase II, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of LAU-7b administered once-daily for 6 months for the treatment of CF.

Cystic Fibrosis

Laurent Pharmaceuticals Inc.166 participantsStarted Nov 2018

Long Beach, California, United States • Los Angeles, California, United States • Sacramento, California, United States +37 more locations

Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)

A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Find Trials by Condition in Salt Lake City

Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

Atrasentan in Patients With IgA Nephropathy

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Study of Artelon FLEXBAND® for Patients Undergoing Soft Tissue Reconstruction of the Anterior Talofibular Ligament (ATFL) to Treat Lateral Ankle Instability

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)